Vir Biotechnology, Inc. (VIR) — DEF 14A Filings
All DEF 14A filings from Vir Biotechnology, Inc.. Browse 2 Proxy Statement reports with AI-powered summaries and risk analysis.
DEF 14A Filings (2)
-
Vir Biotechnology DEF 14A: Executive Compensation Details
— Apr 17, 2025 Risk: low
Vir Biotechnology, Inc. filed a DEF 14A on April 17, 2025, for the fiscal year ending December 31, 2024. The filing details executive compensation and board mem -
Vir Biotechnology, Inc. Announces 2024 Annual Meeting of Stockholders
— Apr 19, 2024 Risk: low
Vir Biotechnology, Inc. (VIR) filed a Proxy Statement (DEF 14A) with the SEC on April 19, 2024. Annual Meeting scheduled for May 29, 2024, at 9:00 a.m. Pacific
Popular Companies
AAPL · TSLA · MSFT · AMZN · GOOGL · META · NVDA · JPM · BRK-B · V · JNJ · UNH · XOM · WMT · MA · PG · HD · DIS · BAC · NFLX